The effect of Jollab beverage on fatigue and happiness in patients with multiple sclerosis - Trial IRCT20150713023190N12
Access comprehensive clinical trial information for IRCT20150713023190N12 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by Rafsanjan University of Medical Sciences and is currently Completed. The study focuses on Multiple sclerosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20150713023190N12
Phase 2/3
Completed
other
Trial Details
Iranian Registry Of Clinical Trial • IRCT20150713023190N12
The effect of Jollab beverage on fatigue and happiness in patients with multiple sclerosis
Investigation the effect of Jollab beverage on fatigue and happiness in patients with multiple sclerosis referring to the MS Association of Rafsanjan
Study Focus
Sponsor & Location
Rafsanjan University of Medical Sciences
Iran
Timeline & Enrollment
Phase 2/3
Jun 05, 2022
N/A
ICD-10 Classifications
Multiple sclerosis
Progressive systemic sclerosis
Systemic sclerosis
Systemic sclerosis, unspecified
Diffuse sclerosis
Data Source
Iranian Registry Of Clinical Trial
IRCT20150713023190N12
Non-Device Trial